• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性乳腺癌患者循环肿瘤细胞与外周 T 细胞的关系。

Relationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancer.

机构信息

Department of Obstetrics and Gynecology,University of Tuebingen, Calwer Straße. 7, 72076 Tuebingen, Germany.

出版信息

Anticancer Res. 2013 May;33(5):2233-8.

PMID:23645781
Abstract

BACKGROUND

Detection of circulating tumor cells (CTCs) in the peripheral blood of patients with primary breast cancer is associated with poor clinical outcome. Recent studies have found evidence for immunological influence on tumor cell dormancy. We therefore investigated the relationship between peripheral T-cells and CTCs, as immunological factors may contribute to the fate of CTCs.

MATERIALS AND METHODS

The peripheral blood immune status of 116 patients with primary breast cancer was analyzed by flow cytometry. Results were correlated with the presence of CTCs and clinicopathological parameters of these patients.

RESULTS

Appearance of CTCs was significantly associated with grade III tumors (p<0.05). Interestingly, CTC-positive patients presented with a significant increase of peripheral CD95(FAS)-positive T-helper cells. As immune response is regulated by CD95(APO-1/FAS)-CD95ligand interaction and tumor cells induce apoptosis via the CD95/CD95L (ligand) pathway, this might lead to tumor cell escape by apoptotic T-helper cells.

CONCLUSION

Absence of T-cell help at the time of priming may result in a loss of long-term antigen-activation of CD8 lymphocytes and could lead to an ineffective anti-tumor cell response. This might contribute to systemic immunosuppression and open the door for tumor cell dormancy.

摘要

背景

原发性乳腺癌患者外周血循环肿瘤细胞(CTC)的检测与不良临床结局相关。最近的研究发现肿瘤细胞休眠存在免疫影响的证据。因此,我们研究了外周 T 细胞与 CTC 之间的关系,因为免疫因素可能影响 CTC 的命运。

材料和方法

采用流式细胞术分析 116 例原发性乳腺癌患者外周血免疫状态。将结果与这些患者 CTC 的存在及临床病理参数相关联。

结果

CTC 的出现与 III 级肿瘤显著相关(p<0.05)。有趣的是,CTC 阳性患者外周 CD95(FAS)阳性辅助性 T 细胞显著增加。由于免疫反应受 CD95(APO-1/FAS)-CD95 配体相互作用调节,且肿瘤细胞通过 CD95/CD95L(配体)途径诱导细胞凋亡,这可能导致凋亡辅助性 T 细胞逃避肿瘤细胞。

结论

在初始阶段缺乏 T 细胞辅助可能导致 CD8 淋巴细胞的长期抗原激活丧失,并可能导致抗肿瘤细胞反应无效。这可能导致全身性免疫抑制,并为肿瘤细胞休眠打开大门。

相似文献

1
Relationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancer.原发性乳腺癌患者循环肿瘤细胞与外周 T 细胞的关系。
Anticancer Res. 2013 May;33(5):2233-8.
2
Relationship Between Hematogenous Tumor Cell Dissemination and Cellular Immunity in DCIS Patients.导管原位癌患者血行肿瘤细胞播散与细胞免疫之间的关系
Anticancer Res. 2016 May;36(5):2345-51.
3
[Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].[乳腺癌患者外周血循环肿瘤细胞的检测及临床意义]
Ai Zheng. 2005 Jul;24(7):837-41.
4
Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy.对有肿瘤休眠可能的早期乳腺癌女性循环肿瘤细胞中增殖和凋亡标志物的评估。
Breast Cancer Res. 2014 Nov 29;16(6):485. doi: 10.1186/s13058-014-0485-8.
5
Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.循环转化生长因子-β(TGF-β)和趋化因子(C-X-C 基序)配体-1(CXCL1)水平作为转移性乳腺癌患者循环肿瘤细胞远处播散的预测指标。
Anticancer Res. 2013 Apr;33(4):1491-7.
6
HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.人表皮生长因子受体2(HER2)阳性循环肿瘤细胞表明I至III期乳腺癌患者的临床预后较差。
Clin Cancer Res. 2006 Mar 15;12(6):1715-20. doi: 10.1158/1078-0432.CCR-05-2087.
7
The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature.通过 RT-PCR 检测循环肿瘤细胞(CTCs)在乳腺癌中的预后作用:对已发表文献的荟萃分析。
Breast Cancer Res Treat. 2011 Dec;130(3):809-16. doi: 10.1007/s10549-011-1379-4. Epub 2011 Feb 11.
8
Apoptosis-related proteins (Fas, Fas ligand, bcl-2 and p53) in different types of human breast tumors.不同类型人类乳腺肿瘤中的凋亡相关蛋白(Fas、Fas配体、bcl-2和p53)
Oncol Rep. 2002 Sep-Oct;9(5):977-80.
9
Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.建立循环肿瘤细胞数量与转移性乳腺癌预后之间的关系模型。
Breast Cancer Res Treat. 2010 Jul;122(1):211-7. doi: 10.1007/s10549-009-0668-7. Epub 2009 Dec 6.
10
Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients.从乳腺癌患者中分离具有侵袭表型的循环上皮和肿瘤祖细胞。
Int J Cancer. 2010 Feb 1;126(3):669-83. doi: 10.1002/ijc.24814.

引用本文的文献

1
Fibrin as the mediator of tumor cell interaction with platelets.纤维蛋白作为肿瘤细胞与血小板相互作用的介质。
J Mol Med (Berl). 2025 Aug 5. doi: 10.1007/s00109-025-02580-7.
2
Dynamics of T cell subpopulations and plasma cytokines during the first year of antineoplastic therapy in patients with breast cancer: the BEGYN-1 study.乳腺癌患者抗肿瘤治疗第一年期间T细胞亚群和血浆细胞因子的动态变化:BEGYN-1研究
Breast Cancer Res. 2025 Apr 1;27(1):50. doi: 10.1186/s13058-025-01997-9.
3
Circulating Tumor Microenvironment in Metastasis.转移中的循环肿瘤微环境
Cancer Res. 2025 Apr 15;85(8):1354-1367. doi: 10.1158/0008-5472.CAN-24-1241.
4
Prognostic Value of Fas/Fas Ligand Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Patients with Metastatic Breast Cancer.Fas/Fas配体表达对转移性乳腺癌患者外周血循环肿瘤细胞(CTC)和免疫细胞的预后价值
Cancers (Basel). 2024 Aug 23;16(17):2927. doi: 10.3390/cancers16172927.
5
Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells.表面组学:循环肿瘤细胞免疫逃逸机制发现的新时代。
Mol Oncol. 2024 May 22. doi: 10.1002/1878-0261.13665.
6
Survival mechanisms of circulating tumor cells and their implications for cancer treatment.循环肿瘤细胞的生存机制及其对癌症治疗的意义。
Cancer Metastasis Rev. 2024 Sep;43(3):941-957. doi: 10.1007/s10555-024-10178-7. Epub 2024 Mar 4.
7
Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma.循环肿瘤细胞参与微血管侵犯的形成,并影响肝细胞癌的临床结局。
Front Genet. 2023 Nov 2;14:1265866. doi: 10.3389/fgene.2023.1265866. eCollection 2023.
8
Prognostic implications of systemic immune-inflammation index in patients with bone metastases from hepatocellular carcinoma treated with radiotherapy.全身免疫炎症指数对接受放疗的肝细胞癌骨转移患者的预后影响
Front Oncol. 2023 May 12;13:1076428. doi: 10.3389/fonc.2023.1076428. eCollection 2023.
9
Molecules promoting circulating clusters of cancer cells suggest novel therapeutic targets for treatment of metastatic cancers.促进循环肿瘤细胞簇的分子为转移性癌症的治疗提供了新的治疗靶点。
Front Immunol. 2023 Mar 15;14:1099921. doi: 10.3389/fimmu.2023.1099921. eCollection 2023.
10
The Utility of Pre-Treatment Inflammation Markers as Associative Factors to the Adverse Outcomes of Vulvar Cancer: A Study on Staging, Nodal Involvement, and Metastasis Models.治疗前炎症标志物作为外阴癌不良结局相关因素的效用:一项关于分期、淋巴结受累及转移模型的研究
J Clin Med. 2022 Dec 22;12(1):96. doi: 10.3390/jcm12010096.